Sfoglia per Rivista
Labile plasma iron levels in heavily iron-overloaded patients with transfusion-dependent anaemias in response to deferasirox therapy : results from the large-scale, prospective 1-year EPIC trial
2009 A. Kattamis, A. El Beshlawy, J.F. Seymour, C.K. Li, H. Nick, D. Habr, G. Domokos, B. Roubert, M.D. Cappellini
A laboratory-based scoring system predicts early treatment in Rai 0 chronic lymphocytic leukemia
2019 J.A. Cohen, F.M. Rossi, A. Zucchetto, R. Bomben, L. Terzi-di-Bergamo, K.G. Rabe, M. Degan, A. Steffan, J. Polesel, E. Santinelli, I. Innocenti, G. Cutrona, G. D' Arena, G. Pozzato, F. Zaja, A. Chiarenza, D. Rossi, F. Di Raimondo, L. Laurenti, M. Gentile, F. Morabito, A. Neri, M. Ferrarini, C.D. Fegan, C.J. Pepper, G. Del Poeta, S.A. Parikh, N.E. Kay, V. Gattei
Lenalidomide plus low dose dexamethasone as first line therapy in patients with primary plasma cell leukemia : planned interim analysis of a pilot study from the gimema-italian myeloma network
2010 P. Musto, F. D'Auria, M.T. Petrucci, F. Morabito, F. Nobile, M. Offidani, F. Di Raimondo, A. Falcone, R. Lerose, E. Zifarone, A. Zonno, V. Callea, A. Levi, C. Mazzone, G. Pietrantuono, M.C. Martorelli, O. Villani, R. Guariglia, G.R. Mansueto, V. Grieco, G. Bianchino, A. Neri, K. Todoerti, P. Omedè, S. Bringhen, M. Cavo, M. Boccadoro, A. Palumbo
Lenalidomide, melophalan, prednisone and thalidomide (RMPT) for relapsed/refractory multiple myeloma
2008 A. Palumbo, P. Falco, G. Sanpaolo, A. Falcone, V. Ferderico, I. Canepa, M. Crugnola, L. Baldini, S. Caltagirone, A. Larocca, F. Gay, V. Magarotto, M.T. Petrucci, M. Boccadoro
Lessons from very severe, refractory and fatal primary autoimmune haemolytic anaemias
2015 W. Barcellini, B. Fattizzo, A. Zaninoni, F. Nesa, A. Zanella, A. Cortelezzi
Leucocytosis is a risk factor for recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia
2009 V. De Stefano, T. Za, E. Rossi, A.M. Vannucchi, M. Ruggeri, E. Elli, C. Micò, A. Tieghi, R. Cacciola, C. Santoro, G. Gerli, N. Vianelli, P. Guglielmelli, L. Pieri, F. Scognamiglio, F. Rodeghiero, E.M. Pogliani, G. Finazzi, L. Gugliotta, G. Leone, T. Barbui
Leukocyte counts in professional football players
2003 A. Dolci, G. Nanni, G. Sisca, B. Costantino, A. Baldari, G. Palaia, G. Banfi
Leukocytosis is a risk factor for recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia
2009 V. De Stefano, T. Za, E. Rossi, A.M. Vannucchi, M. Ruggeri, E. Elli, C. Micò, A. Tieghi, R.R. Cacciola, C. Santoro, G. Gerli, N. Vianelli, P. Guglielmelli, L. Pieri, F. Scognamiglio, F. Rodeghiero, E.M. Pogliani, G. Finazzi, L. Gugliotta, G. Leone, T. Barbui
Levels of coagulation factors and venous thromboembolism
2003 A. Tripodi
Lipid peroxidation and inflammatory status during TKI treatment in chronic myeloid leukemia patients: interim analysis of a prospective multicenter study
2017 A. Sicuranza, L. Aprile, E. Abruzzese, A. Iurlo, S. Galimberti, A. Gozzini, N. Sgherza, L. Puccetti, G. Papini, D. Cattaneo, F. Stagno, F. Di Raimondo, G. Specchia, U. Occhini, R. Lemoli, M. Breccia, L. Luciano, A. Bosi, M. Petrini, M. Bocchia
Liver fibrosis in adult thalassemia patients assessed by transient elastography
2008 E. Cassinerio, M. Fraquelli, M. Fasulo, C. Cesaretti, P. Pattoneri, C. Rigamonti, D. Conte, M.D. Cappellini
Liver iron concentration and morbidity in patients with thalassemia intermedia
2011 K. Musallam, J. Wood, M.D. Cappellini, I. Motta, H. Tamim, A. Taher
Long non-coding RNA NEAT1 shows high expression unrelated to molecular features and clinical outcome in multiple myeloma
2019 E. Taiana, D. Ronchetti, V. Favasuli, K. Todoerti, M. Manzoni, N. Amodio, P. Tassone, L. Agnelli, A. Neri
Long-term molecular remission after conventional chemotherapy in a patient with Philadelphia-negative acute lymphoblastic leukemia
1996 M. Ladetto, P. Corradini, M. Astolfi, S. Campana, C. Tarella, A. Pileri
Long-term mortality rate for cardiovascular disease in 656 chronic myeloid leukaemia patients treated with second-and third-generation tyrosine kinase inhibitors
2019 G. Caocci, O. Mulas, M. Annunziata, L. Luciano, E. Abruzzese, M. Bonifacio, E.M. Orlandi, F. Albano, S. Galimberti, A. Iurlo, P. Pregno, N. Sgherza, B. Martino, G. Binotto, F. Castagnetti, A. Gozzini, M. Bocchia, C. Fozza, F. Stagno, M.P. Simula, F. De Gregorio, M. Trawinska, L. Scaffidi, C. Elena, I. Attolico, C. Baratè, D. Cattaneo, F. Pirillo, G. Gugliotta, A. Sicuranza, M. Molica, G. La Nasa, R. Foà, M. Breccia
Long-term neuropsychological sequelae, emotional wellbeing and quality of life in patients with acquired thrombotic thrombocytopenic purpura
2020 S. Riva, I. Mancini, A. Maino, B. Ferrari, A. Artoni, P. Agosti, F. Peyvandi
The long-term outcome of high-risk follicular lymphoma patients receiving intensive therapy with autograft as primary treatment : results from three consecutive prospective trials performed in Italy over the past 18 years
2009 C. Tarella, M. Ladetto, M. Ruella, R. Passera, A. Pileri, A.M. Gianni, P. Corradini
Long-term outcome of ric-allo SCT for myeloma
2007 V. Montefusco, F. Ciceri, J. Peccatori, L. Farina, A. Oliveri, K. Aprile Hoenstaufen, G. Lambertenghi Deliliers, A.M. Gianni, M. Bregni, P. Corradini
Long-term results of a risk-adapted approach to melphalan conditioning in autologous peripheral blood stem cell transplantation for primary (AL) amyloidosis
2006 V. Perfetti, S. Siena, G. Palladini, M. Bregni, M. Di Nicola, L. Obici, M. Magni, L. Brunetti, A.M. Gianni, G. Merlini
Low dose alemtuzumab in fludarabine-refractory chronic lymphocytic leukemia
2011 G. Gritti, G. Reda, F. Maura, A. Piciocchi, L. Baldini, S. Molica, A. Neri, A. Cortelezzi
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile